Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Raben currently holds 47,413 shares of Bicara Therapeutics Inc. (BCAX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Raben has been a net seller of BCAX stock. They have purchased $0 and sold $1.0M worth of shares.
David Raben's most recent insider trade was on Mar 25, 2026, when they sold 5,500 shares at $0.00 per share.
David Raben serves as Executive at Bicara Therapeutics Inc. (BCAX). They have executed 18 insider transactions totaling $1.0M over their tenure at the company.
David Raben holds the position of Executive at Bicara Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
David Raben has shown a selling trading pattern, with $0 in total purchases and $1.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Raben was on Oct 9, 2025, when they sold $405.9K worth of BCAX shares. This transaction involved 22,000 shares at $18.45 per share.
David Raben currently owns 47,413 shares of Bicara Therapeutics Inc. (BCAX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Raben's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Raben has 18 Form 4 filings on record as an insider at Bicara Therapeutics Inc..
Set alerts for David Raben and 40,000+ other insiders.